The Food & Drug Administration announced last week that the Ozempic and Wegovy shortage for Novo Nordisk‘s (NYSE:NVO) was ...
Many employers and insurers are scaling back coverage of Wegovy and Zepbound, and a key government program, Medicare, doesn’t ...
We recently published a list of Renaissance Technologies Portfolio: Top 10 Stock Picks. In this article, we are going to take ...
Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...
11h
Axios Vitals on MSNCopycat Ozempic makers brace for crackdownMakers of copycat weight-loss drugs and digital health companies that sell them are bracing for upheaval now that the Food ...
Uber CEO Dara Khosrowshahi says Tesla will go it alone at the start of its self-driving robotaxi journey. The Singapore-based company expects to raise $2.58 billion from the sale of its remaining ...
The current state of health services highlights crucial sectors facing disruptions and developments, from US foreign aid freezes affecting disease control supply chains, to the FDA's actions on new ...
High-end brands are churning through creative directors as they try to revive sales.
UnitedHealth Group slid after The Wall Street Journal reported that the Department of Justice was probing the insurance giant's Medicare billing practices. The company, which had already faced a ...
Shares of obesity-drug maker Novo Nordisk rose Friday after the Food and Drug Administration declared that the company’s popular medications Ozempic and Wegovy were no longer in shortage. A shortage o ...
The Justice Department has launched an investigation into the company's Medicare billing practices, [The Wall Street Journal reported]( ...
The FDA’s decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results